Morning Industry Symposium:
Recurrence risk and adjuvant treatment decision-making in HR+/HER2− early breast cancer
Supported by Novartis

 

Saturday, October 10, 2026 | Hall B (Great Hall 2)
07:30-08:30
Light refreshments will be served outside the hall from 07:00-07:30 for session participants only.
Admission to this symposium is included as part of the congress registration

Chairperson: Richard de Boer, Melbourne, Australia
07:30-07:50 Opening presentation
Richard de Boer, Melbourne,Australia
07:50-08:20 Case-based Panel Discussion
Sanjeev Kumar, Sydney, Australia
Nicole McCarthy, Brisbane, Australia
08:20-08:30 Audience Q&A and wrap-up

 

Skip to content